Paxil Generics On Hold After Court Rejects FDA “Shared Exclusivity” Policy

No more generic versions of GlaxoSmithKline's Paxil will be approved before early March under a court decision rejecting FDA's approach to "shared exclusivity.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet